Skip to main navigation Skip to search Skip to main content

Correction to: Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses (Journal of Translational Medicine, (2024), 22, 1, (524), 10.1186/s12967-024-05339-9)

  • Riley M. Larkin
  • , Diana C. Lopez
  • , Yvette L. Robbins
  • , Wiem Lassoued
  • , Kenneth Canubas
  • , Andrew Warner
  • , Baktiar Karim
  • , Ksenia Vulikh
  • , James W. Hodge
  • , Charalampos S. Floudas
  • , James L. Gulley
  • , Gary L. Gallia
  • , Clint T. Allen
  • , Nyall R. London

Research output: Contribution to journalComment/debatepeer-review

Abstract

Following publication of the original article [1], we have been notified that there was a mistake in Copyright line.

Original languageEnglish (US)
Article number836
JournalJournal of translational medicine
Volume22
Issue number1
DOIs
StatePublished - Dec 2024

ASJC Scopus subject areas

  • General Medicine
  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Correction to: Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses (Journal of Translational Medicine, (2024), 22, 1, (524), 10.1186/s12967-024-05339-9)'. Together they form a unique fingerprint.

Cite this